Why Cogent Biosciences, Inc. (COGT) Stock Fell 5.7% on Oct 13, 2026
What happened
Cogent Biosciences fell 3.93% to $28.61, with selling pressure linked to insider transactions reported by established finance sources (Yahoo Finance, Investing.com). Volume remained below average at 0.69x the expected pace 170 minutes into the session, suggesting limited institutional participation in the decline.
Earnings release scheduled for November 6, 2026 (date pending confirmation); monitor insider filings and any guidance updates.
Frequently asked questions
Why did Cogent Biosciences, Inc. (COGT) stock fall on Oct 13, 2026?
Cogent Biosciences fell 3.93% to $28.61, with selling pressure linked to insider transactions reported by established finance sources (Yahoo Finance, Investing.com). Volume remained below average at 0.69x the expected pace 170 minutes into the session, suggesting limited institutional participation in the decline.
How much did COGT stock fall on Oct 13, 2026?
COGT fell 5.7% during the Oct 13, 2026 trading session.